未登录

M

Markku Koulu

University of Turku

H指数:41

被引数:5,593

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metformin induces PGC-1a expression and selectively affects hepatic PGC-1a functions

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2014-04-1170

OAAI

Neuropeptide Y: a novel link between the neuroendocrine system and cholesterol metabolism

ANNALS OF MEDICINE

IF4.3

2009-07-0816

PREAI

Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization

ANNALS OF MEDICINE

IF4.3

2009-07-0870

PREAI

Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy

PHARMACOLOGICAL REVIEWS

IF17.3

2009-06-01446

OAAI

Stress-Induced Hypertension and Increased Sympathetic Activity in Mice Overexpressing Neuropeptide Y in Noradrenergic Neurons

NEUROENDOCRINOLOGY

IF2.8

2008-12-2040

PREAI

Transgenic mice overexpressing neuropeptide Y in noradrenergic neurons -: A novel model of increased adiposity and impaired glucose tolerance

IF7.5

2008-06-0153

OAAI

Nutrient intake, weight, and Leu7Pro polymorphism in prepro-neuropeptide Y in children

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2006-11-0113

OAAI

The Leu7Pro polymorphism of preproNPY is associated with decreased insulin secretion, delayed ghrelin suppression, and increased cardiovascular responsiveness to norepinephrine during oral glucose tolerance test

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2005-06-0113

OAAI

Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women

IF3.6

2004-09-018

PREAI

Serum leptin concentration poorly reflects growth and energy and nutrient intake in young children

IF6.4

2004-05-0112

PREAI

Leucine 7 to proline 7 polymorphism in preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients

IF16.6

2004-02-0139

OAAI

Changes in diurnal sympathoadrenal balance and pituitary hormone secretion in subjects with Leu7Pro polymorphism in the prepro-neuropeptide Y

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2003-07-0136

PREAI

Enhanced endothelium-dependent vasodilation in subjects with proline7 substitution in the signal peptide of neuropeptide Y

ATHEROSCLEROSIS

IF5.7

2003-04-0129

PREAI

The impact of the leucine 7 to proline 7 polymorphism of the neuropeptide Y gene on postprandial lipemia and on the response of serum total and lipoprotein lipids to a reduced fat diet

European Journal of Clinical Nutrition

IF3.3

2002-02-2014

PREAI

Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men

ATHEROSCLEROSIS

IF5.7

2001-11-0194

PREAI

Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans

IF4.2

2001-05-01128

PREAI

CYP2A6 genotype and smoking

MOLECULAR PSYCHIATRY

IF10.1

2000-06-3031

PREAI

Effects of chronic celiprolol treatment on brown fat, feeding, and drinking in fa/fa Zucker rats

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2000-04-010

PRE

Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism

MOLECULAR PSYCHIATRY

IF10.1

1999-05-18165

PREAI

Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels

NATURE MEDICINE

IF50

1998-12-01199

PREAI